Vero Bioscience
1 known investors
Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
Founders & leadership
Investors · 1
Competitors · 5
by search overlap
VERO Biotech14 shared keywordsVERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
Verana Health11 shared keywordsVerana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.
Veratx10 shared keywordsVera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
Labcorp8 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Life Biosciences7 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Companies competing with Vero Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vero Bioscience do?
- Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
- Who founded Vero Bioscience?
- Vero Bioscience was founded by Tony Wyss-Coray.
- Who are Vero Bioscience's investors?
- Vero Bioscience's investors include Khosla Ventures.